(2022). Correction to: One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients. Wiley.
Chicago Style (17th ed.) CitationCorrection to: One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients. Wiley, 2022.
MLA (9th ed.) CitationCorrection to: One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients. Wiley, 2022.
Warning: These citations may not always be 100% accurate.